All Articles

All Articles2020-08-12T09:41:23-04:00

AIM ImmunoTech Provides Third Quarter 2020 Business Update

OCALA, Fla., Nov. 13, 2020 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of [...]